Inicio | Buscar

Buscar

Resultados de la búsqueda

An Observational Study to Evaluate the Real-World Clinical Management and Outcomes of ALK-Positive Advanced NSCLC Participants Treated With Alectinib

... Medical Doctor, First degree specialist in oncology Affiliation:  ... Havana, National Institute of Oncology and Radiobiology (INOR), Dra. Yoanna Flores, Medical Doctor, First ...

Clinical Trials - ROCHE - 31/08/2021 - 10:58am

Un estudio observacional para evaluar el manejo clínico y los resultados en el mundo real de los participantes de CPCNP avanzado ALK positivos tratados con alectinib

... instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365–76. Arbour KC, Riely GJ. Diagnosis ... Cancer Network® (NCCN) Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Non-Small Cell Lung Cancer. Version 3.2020 – 11 ...

Ensayos Clínicos - ROCHE - 31/08/2021 - 10:57am

Estudio para evaluar la preferencia de los pacientes y la satisfacción de la administración subcutánea de la combinación de dosis fija de Pertuzumab y Trastuzumab en participantes con cáncer de mama temprano positivo a HER2

... randomised multicentre, open-label, phase 2 trial. Lancet Oncology 2012;13(1):25-32. Gianni L, Pienkowski T, Im YH et al. 5-Year ... BO, Aft R et al. NCCN clinical practice guidelines in oncology (NCCN Guidelines®). Breast Cancer. Version I.2018 [internet]. ...

Ensayos Clínicos - ROCHE - 18/08/2021 - 6:58pm

Estudio para describir el diagnóstico, el tratamiento contra el cáncer y el resultado clínico en pacientes con cáncer de mama recién diagnosticado en América Latina

... Latin American Cooperative Oncology Group (LACOG) Promotor ... Latin American Cooperative Oncology Group (LACOG) Participación del ...

Ensayos Clínicos - ROCHE - 18/08/2021 - 6:47pm

A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer

... Medical Doctor, Second degree specialist in oncology Affiliation:  ... Havana, National Institute of Oncology and Radiobiology (INOR), Dr. Elías Gracia Medina, Medical Doctor, ...

Clinical Trials - ROCHE - 18/08/2021 - 6:13pm

A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America

... Latin American Cooperative Oncology Group (LACOG) Primary ... Latin American Cooperative Oncology Group (LACOG) Source(s) of monetary ...

Clinical Trials - ROCHE - 18/08/2021 - 6:07pm

NAcGM3/VSSP/Montanide ISA 51 formulation in HIV, phase II.

... First Degree Specialist in Oncology Affiliation:  ... First Degree Specialist in Oncology Affiliation:  ...

Clinical Trials - CIM - 19/04/2021 - 3:41pm

VSSP in renal cell carcinoma

... First grade specialist in Oncology Affiliation:  ...

Clinical Trials - CIM - 08/04/2021 - 4:19pm

Inmunoterapia con la combinación de NGcGM3/VSSP y nimotuzumab en pacientes con cáncer avanzado de pulmón de células no pequeñas (CPCNP)

... NGcGM3. 7. Estado general según el Eastern Cooperative Oncology Group (ECOG) menor igual 2. 8. Pacientes con expectativa de vida de ... 1995;14:350. 9. NCCN Clinical Practice Guidelines in Oncology. NSCLC. Version I.2013 www.nccn.org 10. Thongprasert S, Sanguanmitra ...

Ensayos Clínicos - CIM - 21/12/2020 - 11:38am

Combined NGcGM3/VSSP and Nimotuzumab in advanced non-small cell lung cancer (NSCLC)

... Havana, “National Institute of Oncology and Radiobiology". Yoanna Ivette Flores Vega, MD. First degree specialist in Oncology Research ethics committees:  ...

Clinical Trials - CIM - 21/12/2020 - 11:38am